ArticleFrontiers in immunology2024

Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinoma.

Takahiro Tsujikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.